Charles River Laboratories | CRL - 普通股股本



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 8.11B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


普通股股本 更改 日
Agilent USD 282.7M 358K 2025-12
Align Technology USD 71.62M 133K 2026-03
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Bruker USD 152.22M 282K 2026-03
Cardinal Health USD 235M 1000K 2026-03
Charles River Laboratories USD 48.17M 1.05M 2026-03
Cigna USD 264.6M 1.14M 2026-03
Concord Medical Services Hldg CNY 130.25M 130.15M 2025-06
CVS Health USD 1.27B 2M 2026-03
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 200.3M 700K 2026-03
Elevance Health USD 217.37M 4.87M 2026-03
Humana USD 120.06M 529K 2026-03
Illumina USD 151.91M 893K 2026-03
Incyte USD 199.95M 1.49M 2026-03
Intrexon USD 0 0 2024-06
IQVIA Holdings USD 166.9M 2.7M 2026-03
Laboratory Of America USD 82.3M 100K 2026-03
Lakefront Biotherapeutics EUR 65.9M 0 2026-03
Lonza CHF 68.64M 0 2025-12
McKesson USD 280M 156M 2025-12
Merck EUR 434.78M 0 2026-03
Mettler Toledo International USD 20.25M 179.94K 2026-03
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
Quest Diagnostics USD 111M 1000K 2026-03
Revvity USD 111.8M 1.57M 2026-03
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
United Therapeutics USD 42.16M 1.49M 2026-03
UnitedHealth USD 907.68M 1.84M 2026-03
Veradigm USD 106.07M 103.28M 2022-12
Waters USD 98.17M 89K 2026-03
West Pharmaceutical Services USD 70.9M 1.1M 2026-03